GOLDENWELL BIOTECH, INC. Cash and Restricted Cash
GOLDENWELL BIOTECH, INC. (GWLL) had Cash and Restricted Cash of $11.14 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $11.14K.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $13.41K.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $26.77K.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $45.62K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $11.14K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $13.41K 10-Q · filed 2026-07-01 | |
| 2025-12-31 | $26.77K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $45.62K 10-Q/A · filed 2026-06-29 | |
| 2025-06-30 | $76.51K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $17.13K 10-Q · filed 2026-07-01 | |
| 2024-12-31 | $49.40K 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $4.75K 10-Q/A · filed 2026-06-29 | |
| 2024-06-30 | $25.72K 10-Q/A · filed 2026-06-26 | |
| 2024-03-31 | $24.22K 10-Q/A · filed 2026-06-26 | |
| 2023-12-31 | $53.23K 10-K · filed 2026-07-01 | |
| 2023-09-30 | $11.92K 10-Q · filed 2024-11-26 | |
| 2023-06-30 | $17.13K 10-Q · filed 2024-08-22 | |
| 2023-03-31 | $44.08K 10-Q · filed 2024-08-22 | |
| 2022-12-31 | $46.00K 10-K · filed 2025-05-15 | |
| 2022-09-30 | $58.09K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $42.86K 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $213.56K 10-Q · filed 2023-11-13 | $67.90K 10-Q · filed 2023-05-19 |
| 2021-12-31 | $213.56K 10-K · filed 2024-04-12 | |
| 2021-09-30 | $232.93K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $245.44K 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $248.57K 10-K · filed 2023-04-13 | |
| 2019-12-31 | $246.59K 10-K/A · filed 2023-02-06 |